|
I.G. Bakulin, E.V. Vinnytskaya, Yu.G. Sandler, V.A. Keiyan, S.V.Rodionova
ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
|
№2 / 2016
|
|
P.V. Seliverstov, E.M. Prikhodko, V.P. Dobritsa, V.G. Radchenko
SOME PROBLEMS OF DIAGNOSIS, TREATMENT AND PREVENTION OF NONALCOHOLIC FATTY LIVER DISEASE
|
№2 / 2015
|
|
V.V. Tsukanov, A.V. Vasyutin, Yu.L. Tonkikh, O.S. Amelchugova
THERAPY OF NONALCOHOLIC FATTY LIVER DISEASE. IS THERE A PLACE FOR HEPATOPROTECTORS?
|
№18 / 2014
|
|
V.B. Grinevich, E.I. Sas, Yu.A. Kravchuk, O.I. Efimov
AASLD GUIDLINES FOR THE TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE. POTENTIALS FOR THE USE IN RUSSIA
|
№2 / 2014
|
|
V.V. Tsukanov, O.S. Amelchugova, A.V. Vasyutin, Yu.L.Tonkikh
PATIENT WITH NAFLD: ALGORITHM FOR DIAGNOSIS AND TREATMENT
|
№18 / 2013
|
|
S. M. Alekhin, M. N. Somova
NONALCOHOLIC FATTY LIVER DISEASE: NEW POTENTIALS FOR THE COMBINED THERAPY
|
№10 / 2013
|
|
A.S.Ametov
Type 2 Diabetes Mellitus And Non-alcoholic Fatty Liver Disease: Guidelines For Endocrinologists
|
№5 / 2013
|
|
Ye.V. Golovanova
Thiogamma In Nonalcoholic Fatty Liver Disease
|
№7 / 2012
|
|
L.A. Zvenigorodskaya, E.A. Cherkashova, N.G. Samsonova
Hepatoprotectors In The Treatment Of Nonalcoholic Fatty Liver Disease
|
№15 / 2011
|
|
I.V. Mayev, V.V. Tsukanov, Ye.V.Lukicheva, A.A. Samsonov, A.V. Vasyutin, I.N. Nikushkina
Prevalence, Pathogenesis And Principles Of Treatment Nonalcoholic Fatty Liver Disease
|
№12 / 2011
|
|
L.A. Zvenigorodskaya
Lipid-lowering Therapy In Patients With Nonalcoholic Fatty Liver Disease
|
№10 / 2011
|
|
N.V. Loseva, Ye.Ye. Moiseyenko
Experience Of Use Of Drug Dibicor In The Complex Therapy Of Non-alcoholic Fatty Liver Disease
|
№15 / 2010
|
Русский
